No, not at the present time. However, using drugs to prevent KS may be
possible in the near future. Given that KSHV has been shown to be a major
culprit in the development of KS lesions, researchers are now looking
at various antiviral drugs to see if they are effective against this virus.
HIV-infected patients who are infected with KSHV and have low CD4+ cell
counts may benefit greatly from these drugs, as they may prevent KS lesions
from occurring in the first place.